We are live on ! Find out more
TIA

Traphagen Investment Advisors Portfolio holdings

AUM $1.4B
1-Year Est. Return 19.32%
This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+19.32%
3 Year Est. Return
+56.29%
5 Year Est. Return
+55.58%
10 Year Est. Return
AUM
$789M
AUM Growth
+$18.4M
Cap. Flow
-$5.21B
Cap. Flow %
-660.3%
Top 10 Hldgs %
68.65%
Holding
175
New
21
Increased
74
Reduced
51
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
151
Kimberly-Clark
KMB
$36.2B
$206K 0.03%
1,705
+1
+0.1% +$129
GNTX icon
152
Gentex
GNTX
$5.03B
$205K 0.03%
+6,300
New +$202K
MO icon
153
Altria Group
MO
$111B
$205K 0.03%
+4,871
New +$215K
FAN icon
154
First Trust Global Wind Energy ETF
FAN
$278M
$204K 0.03%
+14,078
New +$228K
BMY icon
155
Bristol-Myers Squibb
BMY
$133B
$202K 0.03%
3,480
+230
+7% +$14.1K
ROP icon
156
Roper Technologies
ROP
$39.9B
$201K 0.03%
+415
New +$203K
KMI icon
157
Kinder Morgan
KMI
$69.4B
$167K 0.02%
10,085
+6
+0.1% +$103
IOVA icon
158
Iovance Biotherapeutics
IOVA
$2.96B
$164K 0.02%
35,996
+571
+2% +$3.73K
MUJ icon
159
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$653M
$160K 0.02%
+15,857
New +$173K
RC
160
Ready Capital
RC
$319M
$157K 0.02%
15,549
-1,633
-10% -$18K
SIRI icon
161
SiriusXM
SIRI
$9.77B
$58.6K 0.01%
1,296
-64
-5% -$2.98K
CYAN
162
DELISTED
Cyanotech Corp
CYAN
$24.5K ﹤0.01%
30,600
SUNW
163
DELISTED
Sunworks, Inc.
SUNW
$10.9K ﹤0.01%
+21,000
New +$22.5K
BBH icon
164
VanEck Biotech ETF
BBH
$427M
-59,005
Closed -$9.21M
CB icon
165
Chubb
CB
$134B
-1,425
Closed -$274K
DE icon
166
Deere & Co
DE
$164B
-516
Closed -$209K
GIS icon
167
General Mills
GIS
$19.8B
-4,080
Closed -$313K
VEA icon
168
Vanguard FTSE Developed Markets ETF
VEA
$236B
-11,328
Closed -$523K
XBI icon
169
State Street SPDR S&P Biotech ETF
XBI
$10.4B
-98,840
Closed -$8.22M

Similar funds

Traphagen Investment Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Traphagen Investment Advisors held 175 positions worth $789M, up 2.4% from $771M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Traphagen Investment Advisors withdrew a net $5.21B in Q3 2023, closing 12 positions and reducing 51 holdings. Its most notable exit was VanEck Biotech ETF, an estimated $9.21M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.2% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Traphagen Investment Advisors opened a new position in Avantis US Equity ETF worth $80.3M.

  • Traphagen Investment Advisors's largest Q3 2023 buy was Avantis US Equity ETF: 1,095,600 shares worth $80.3M.
  • Traphagen Investment Advisors added most to Goldman Sachs Access Investment Grade Corporate Bond ETF in Q3 2023, an estimated $26.5M increase.
  • Traphagen Investment Advisors's biggest Q3 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $4.96B.
  • Traphagen Investment Advisors fully exited VanEck Biotech ETF in Q3 2023, selling an estimated $9.21M.
  • Traphagen Investment Advisors's ten largest holdings make up 69% of its $789M portfolio in Q3 2023.
  • Traphagen Investment Advisors opened 21 new positions and closed 12 in Q3 2023.
  • Traphagen Investment Advisors's portfolio value rose 2.4% quarter-over-quarter to $789M.

Based on Traphagen Investment Advisors's 13F filing for Q3 2023, filed 17 Jun 2024.